A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments.
With a new NIH grant, investigators in the Tuberculosis Research Unit hope to catalyze research findings made in the lab and at Weill Cornell's GHESKIO clinic in Haiti into new, effective agents to replace current TB therapies.
Hundreds of Cornellians participated in a Big Red version of the "Antiques Road Show" Feb. 6 in New York City. Among the donated items is a piece of the goal post from Penn's Franklin Field taken down in the wake of a famous Cornell football win in 1958.
Dan Huttenlocher, vice provost and dean of Cornell Tech, has been appointed to Corning Incorporated’s board of directors, effective Feb. 3. Huttenlocher will serve on the board’s finance and audit committees.